Adrenolipoma epidemiology and demographics: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Adrenolipoma}} | {{Adrenolipoma}} | ||
{{CMG}} {{AE}} {{AAM}} | |||
{{CMG}} | |||
==Epidemiology and Demographics== | ==Epidemiology and Demographics== | ||
==Incidence== | |||
The incidence varies from 0.08-0.4% at autopsy. | |||
==Gender== | |||
Adrenolipoma affects men and women equally. | |||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
{{WH}} | {{WH}} | ||
{{WS}} | {{WS}} | ||
[[Category:Disease]] | [[Category:Disease]] | ||
[[Category:Endocrine system]] | [[Category:Endocrine system]] | ||
[[Category:Endocrinology]] | [[Category:Endocrinology]] | ||
[[Category:Overview complete]] | [[Category:Overview complete]] | ||
Revision as of 13:03, 8 September 2015
|
Adrenolipoma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Adrenolipoma epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Adrenolipoma epidemiology and demographics |
|
Risk calculators and risk factors for Adrenolipoma epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Ahmad Al Maradni, M.D. [2]
Epidemiology and Demographics
Incidence
The incidence varies from 0.08-0.4% at autopsy.
Gender
Adrenolipoma affects men and women equally.